Emerging from mastectomy

November 10, 2017 by From Mayo Clinic News Network, Mayo Clinic News Network

When she was diagnosed with breast cancer, Margaret Pelikan had two goals: to get rid of the disease and to feel normal afterward. Her team at Mayo Clinic helped her accomplish both.

For eight years, Margaret Pelikan dreaded mammograms.

In 2008, she had been diagnosed with a condition called lobular carcinoma in situ in her left breast. The disorder involves abnormal cell growth, and it increases a person's risk of developing in both breasts.

After having the surgically removed, Margaret took medication to suppress her estrogen production in hopes of decreasing her . But in 2016, her fears were realized. A mammogram showed she had suspicious calcifications in her right breast. Further testing revealed Margaret had breast cancer.

Her local health care provider recommended a lumpectomy and radiation therapy. She went ahead with the lumpectomy. But she was concerned about radiation. Because she was at high-risk for , Margaret feared the disease could come back. If it did, a mastectomy and successful breast reconstruction could be more difficult to achieve if the tissue had received radiation.

As Margaret weighed her options, she decided she wanted another opinion. She turned to Mayo Clinic. Doctors there offered Margaret a new type of surgery and breast reconstruction that would provide the treatment she needed while helping her maintain a positive outlook about her body.

"I joke that I look better than I did before," Margaret says. "And I don't have to continue to live in fear of my annual mammogram."

Explore further: Lumpectomy combined with lift a good option for women with breast cancer

0 shares

Related Stories

Lumpectomy combined with lift a good option for women with breast cancer

October 18, 2017
A collaborative effort between a surgical oncologist and plastic surgeon can provide an opportunity for women diagnosed with breast cancer to not only have the lump removed from the breast, but also get a breast lift during ...

Breast cancer screenings still best for early detection

October 12, 2017
(HealthDay)—Breast cancer is the second leading cause of cancer death among women in the United States, and routine screenings remain the most reliable way to detect the disease early, a breast cancer expert says.

Pregnancy poses no greater risk to breast cancer survivors

October 26, 2017
A recent study published in the Journal of the National Cancer Institute indicates that pregnancy does not incur a greater risk of relapse for survivors of breast cancer. The safety of pregnancy for women with history of ...

Surgical options after a cancer diagnosis in one breast

November 9, 2016
Dear Mayo Clinic: My daughter was diagnosed with breast cancer at 54 and had surgery to remove one breast. Her surgeon told her that it wasn't necessary to remove both breasts, because she was not at high risk for developing ...

Different breast cancer treatment options vary widely in their cost-effectiveness

April 10, 2017
A new study published today in the Journal of the National Cancer Institute indicates that different therapies for early-stage breast cancer have very different relative values. Some therapies may have fewer complications ...

Researchers quantify immune cells associated with future breast cancer risk

February 8, 2017
Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research.

Recommended for you

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.